Expression levels of HIC2 were significantly downregulated in glioma samples compared to control samples, as confirmed by TCGA and GTEx (p < 0.001), GEO (p < 0.001), and CGGA (p < 0.01) databases (Figure 2A). This evidence concerns the gene HIC2 and central nervous system cancer.